Bile resistant bacillus composition secreting high levels of phytase
AssigneeChr. Hansen A/S
InventorsInge Knap, Ane Knarreborg, Thomas Dyrmann Leser, Bente Lund
Life of this patent
Estimating the term…
Abstract
A bacillus composition characterized by fast germination and outgrowth in bile salts (simulated gut environment) and by high-level secretion of phytase. The bacillus composition may be used as supplement in animal feed where it has a probiotic (health promoting) effect and increases the digestion and availability of nutrients from animal feeds.
Claims10
A bacillus composition, which comprises from 105 to 1012 CFU/g bacillus spore cells, wherein the bacillus composition is characterized by:
- (i):
- the bacillus spores have a rapid germination and outgrowth from spore to vegetative cell in presence of a bile salt medium comprising 4 and 6 mM bile salts, defined by that the bacillus spores reaches a vegetative cell growth point of 0.4 OD630 within less than 18 and 19 hours, respectively, wherein the vegetative cell growth point is the point in the growth curve where the OD value starts to increase (due to growth of the vegetative cells) in a continuous way and reaches an OD630 of 0.4;
- (I):
- wherein the bile salt medium is the standard known non-selective Veal Infusion Broth (VIB) medium of example 1 herein supplemented with a bile salt mixture comprising the conjugated bile salts taurodeoxycholate and glycodeoxycholate and the deconjugated bile salt deoxycholate in the proportions 60% of the taurodeoxycholate, 30% of the glycodeoxycholate and 10% of deoxycholate;
- and
- wherein the OD assay analysis is performed by the following steps:
- (a):
- filling a well in a microtiter plate with 0.150 ml bile salt medium having 108 bacillus spores per ml medium (i.e. this is time zero);
- and
- (b):
- incubating the plate at 37° C. under atmospheric conditions and measuring the OD630 values, using a spectrophotometer and with agitation before each reading, to get a representative growth curve over time;
- and
- (ii) the bacillus vegetative cells are producing phytase in an amount of at least 1.25 times more than the reference bacillus cell DSM 19467, wherein the produced phytase amount is measured by the standard phytase assay of example 2 herein after 4 hours growth at 37° C. in the standard known non-selective Heart Infusion Broth (HIB) medium of example 2 herein;
- and
- wherein the phytase assay analysis is performed by the following steps:
- (a):
- making a overnight culture of bacillus vegetative cells in a enriched culture medium;
- and
- (b):
- transferring a 1% inoculum from the overnight culture to HIB medium (i.e. this is time zero) and incubation at 37° C. until phytase activity measurement.
A method for feeding an animal comprising administering the bacillus composition of first aspect and herein described related embodiments to an animal in conjunction with other animal feed ingredients.
A method for screening and isolating a novel bacillus cell comprising the following steps:
- (a):
- selecting and isolating from a pool of individual bacillus spore cells of a new bacillus spore cell that is capable of germinating and outgrowing so rapidly that it reaches a vegetative cell growth point within less than 18 and 19 hours under the conditions of point (i) of first aspect;
- (b):
- making a vegetative bacillus cell from the isolated spore cell of step (a) and mutating the novel selected and isolated cell to get a pool of new individual bacillus vegetative cells;
- (c):
- selecting and isolating from the pool of new individual bacillus vegetative cells of step (b) a new bacillus vegetative cell that is capable of producing phytase in an amount of at least 1.25 times more than the reference bacillus cell deposited as DSM registration number 19467 under the conditions of point (ii) of first aspect;
- and
- (d):
- analyzing the high producing vegetative bacillus cell of step (c) to confirm that it has maintained the rapid germination and outgrowth of step (a) and isolating the selected bacillus cell.
A bacillus cell selected from the group consisting of:
- (a) a Bacillus subtilis cell with registration number DSM 19467;
- (b) a Bacillus subtilis cell with registration number DSM 19489;
- and
- (c) a Bacillus subtilis cell with registration number DSM 19466;
- or a mutant strain thereof, wherein the mutant strain is obtained by using one of the deposited strain as starting material and wherein the mutant strain retains the essential properties of the deposited strain.
Dependencies are inferred from the claim text.